Physician profile
Michael H Lowenstein
NPI 1174630453
$6,557.96
in general payments reported to CMS, 2019-2025
25 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,753 · 2020: $1,784 · 2021: $177 · 2022: $1,947 · 2023: $207 · 2024: $481 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846 · Travel and Lodging: $50.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.19 |
| Travel and Lodging | $50.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,675.55 | 2022 | |
| Boston Scientific Corporation | $1,658.85 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $849.28 | 2019-2025 | Proclaim |
| Medtronic USA, INC. | $498.29 | 2019-2020 | |
| Vertiflex, INC. | $364.00 | 2019 | |
| Biotronik Nro, INC. | $266.28 | 2024 | Prospera |
| Saluda Medical Americas, INC. | $206.66 | 2024-2025 | Evoke |
| Pfizer INC. | $160.68 | 2019-2020 | |
| Nevro Corp. | $160.11 | 2019-2024 | Senza |
| Scilex Pharmaceuticals INC. | $159.86 | 2019-2025 | Ztlido |
| Electronic Waveform Lab, INC. | $112.13 | 2019-2025 | |
| Abbvie INC. | $51.13 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $50.95 | 2019-2020 | |
| Depuy Synthes Sales INC. | $44.19 | 2019-2021 | |
| Fidia Pharma USA INC. | $43.11 | 2019-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $39.16 | 2020-2023 | |
| Collegium Pharmaceutical, INC. | $36.46 | 2019-2020 | |
| Assertio Therapeutics, INC. | $34.15 | 2019 | |
| Amgen INC. | $28.26 | 2019 | |
| Forte Bio-Pharma LLC | $26.07 | 2019-2021 | |
| Curonix LLC | $21.30 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $21.06 | 2022 | |
| Allergan, INC. | $20.60 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.59 | 2019 | |
| Shionogi INC | $14.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lowenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.